News
Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial. In a Phase 3 study, the ...
An influenza vaccine candidate from Moderna showed promising results in a late-stage trial, bringing the drug maker one step ...
A federal vaccine advisory panel voted this week to recommend significant updates to the nation’s respiratory syncytial virus (RSV) and influenza vaccination policies, signaling a new direction ...
RNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed ...
Concerns raised by University of Minnesota’s Dr. David Boulware correct record before a federal vaccine advisory committee ...
The newly appointed members of the CDC’s influential vaccine committee meet Wednesday and Thursday under an unusually rapid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results